European Medicines Agency London, 19 March 2009

First Page		Document Content
Date: 2013-07-21 04:57:45 Health Low molecular weight heparin Deep vein thrombosis Factor X European Medicines Agency Committee for Medicinal Products for Human Use Pharmacovigilance Safety pharmacology Thrombosis Heparins Hematology Medicine		European Medicines Agency London, 19 March 2009 Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 62,68 KB Share Document on Facebook

	PSUR Submissions in Single Assessment via EMA Gateway Webclient An agency of the European Union Presenters of the Day, from EMA DocID: 1rf2q - View Document
	ARTICLE IN PRESS Phytomedicine–250 www.elsevier.de/phymed ESCOP SECTION DocID: 1qy48 - View Document
	Microsoft Word - Implementation Plan - QRD template_3 DocID: 1q3Qb - View Document
	Concept Paper on Guideline on quality and equivalence of topical product - amended DocID: 1giHZ - View Document
	Revised biosimilar quality guideline DocID: 1g0Wz - View Document